Liver fibrosis (LF) is the result of a vicious cycle between inflammation-induced chronic hepatocyte injury and persistent activation of hepatic stellate cells (HSCs).
| INTRODUCTION
Liver fibrosis (LF), characterized by extracellular matrix (ECM) protein production and accumulation, is a vicious cycle between chronic inflammation-induced persistent parenchymal cell injury and activation of consequent wound-healing responses executed mainly by activated myofibroblasts, which define the LF microenvironment (Tsuchida & Friedman, 2017) . Genetic techniques have provided strong evidence that primed hepatic stellate cells (HSCs) are the prominent cellular origin of matrix protein-secreting myofibroblasts (Lee, Wallace, & Friedman, 2015; Trautwein, Friedman, Schuppan, & Pinzani, 2015) . Genetic lineage-tracing analysis performed by Kramann et al. (2015) strongly suggested that glioma-associated oncogene homolog 1 (Gli1) is an in vivo marker of myofibroblast progenitors; thus, HSCs can be traced in vivo using a Gli1 genetic lineage-tracing technique. In addition, both the occurrence and progression of LF are closely related to T-cell-mediated immune responses (Pesce et al., 2006; Wynn, 2004) .
Multiple researches have consolidated the beneficial efficacy of mesenchymal stem cells (MSCs) on treatment of varied inflammatory disease (L. Bai et al., 2012; Rocheteau et al., 2015; Swart et al., 2015) , and the therapeutic effects of MSCs are largely attributable to their profound immunoinhibitive capacity (Horton et al., 2013; Wang, Chen, Cao, & Shi, 2014) . Nevertheless, the uncertainty of the transplanted MSCs poses critical challenge for obtaining predictable therapeutic effects in vivo. The in vivo inflammatory microenvironment is a pivotal necessity for MSCs to execute their immunomodulatory functions (Ren et al., 2008) . The interactions between MSCs and inflammatory microenvironment regulate the immunomodulatory properties of MSCs (Y. Liu et al., 2011) . However, few studies have evaluated the mechanisms through which the inflammatory microenvironment of LF controls the immunoregulatory capability of MSCs.
Autophagy is a highly conservative eukaryotic degradative process, which is a requisite for replying and adapting to environmental alterations (Cadwell, 2016) . Autophagy-related genes (Atgs), including Atg7, Atg12, Atg5 as well as Becn1, regulate autophagosome maturation (Antonioli, Di Rienzo, Piacentini, & Fimia, 2017) . Emerging evidence has confirmed a close link between autophagy and immunomodulation has been confirmed by emerging evidence (Shibutani, Saitoh, Nowag, Münz, & Yoshimori, 2015) . Some studies unveiled that inflammatory microenvironment hindered the immunosuppressive properties of MSCs by priming autophagy (Dang et al., 2014) . Therefore, we hypothesized that the LF microenvironment could also interact with the autophagic and immunoregulatory potential of MSCs and that modulation of autophagy may in turn influence the therapeutic effect of MSCs in LF.
In the current study, we assessed the autophagy activity in transplanted MSCs triggered by hepatic microenvironment in vivo.
We also examined the effect of stimulating MSCs by LF-related cytokines, including tumor necrosis factor (TNF)-α, interferon-γ (IFNγ), and transforming growth factor-β1 (TGF-β1) on autophagy-related gene expression. Furthermore, we evaluated the effect of autophagy inhibition on the antifibrotic activity of MSCs. The findings of this study are expected to provide novel insights into the relationship between autophagy and the immunomodulatory effects of MSCs, and indicate whether autophagy could be considered as a promising therapeutic target for MSCs for treating LF.
| MATERIALS AND METHODS

| Isolation and culture of MSCs
MSCs were enriched from the bone marrow of male C57BL/6 mice and cultured in DMEM-low glucose (cat. no. 01-051-1AC5; BI, Kibbutz Beit Haemek, Israel) containing 10% fetal bovine serum (FBS, cat. no. 10099-141; Gibco, Grand Island, NY) . MSCs were seeded at 2 × 10 6 cells/100-mm culture dish (cat. no. 07-3100; Biologix Group, Jiangsu, China) and cultured for 72 hr in an incubator containing 5% CO 2 at 37°C. To remove floating cells, on the second day, the cultures were rinsed twice with phosphate-buffered saline (PBS 
| In vitro MSC treatment
MSCs were starved or treated with SB, Beijing, China) ,  SB), or TGF-β1 (10 ng/ml, cat. no. 7666-MB-005; R&D Systems, Minneapolis, MN) for 0-24 hr and then subjected to western blot analysis of microtubule-associated protein 1A/1B light chain 3 (MAP1LC3). Cells incubated under starvation served as a positive control. MSCs were stimulated with TNF-α (20 ng/ml), IFN-γ (50 ng/ ml), and TGF-β1 (10 ng/ml) alone or in different combinations for 6 hr. Subsequently, MAP1LC3-I, MAP1LC3-II, and p62 expression levels were measured using western blot analysis. Autophagosome formation was detected by transmission electron microscopy, and MAP1LC3 dot formation in MSCs was visualized by immunofluorescence staining. Additionally, shNC-MSCs and shBecn1-MSCs were incubated in absence or presence of TNF-α (20 ng/ml), IFN-γ (50 ng/ ml), or TGF-β1 (10 ng/ml) for 6 hr. Subsequently, Becn1 messenger RNA (mRNA) levels were measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR). In addition, protein expression levels of MAP1LC3-I, MAP1LC3-II, p62, and BECN1 were detected using immunoblotting. To further evaluate the WANG ET AL.
| 2723
effects of Becn1 knockdown on expression of prostaglandinendoperoxide synthase 2 (PTGS2) in MSCs, shNC-MSCs were treated with or without 3-methyladenine (3-MA, cat. no. M9281; Sigma, St. Louis, MO), and shBecn1-MSCs were incubated for indicated time with or without rapamycin (cat. no. 553210; Sigma) under stimulation with TNF-α (20 ng/ml), IFN-γ (50 ng/ml), and TGF-β1 (10 ng/ml) for 12 hr.
| Transmission electron microscopy
After starvation or combined treatment of TNF-α, IFN-γ, and TGF-β1, MSCs were rinsed with PBS and fixed with 2% glutaraldehyde (cat. no. G5882; Sigma) in 0.1 M phosphate buffer (pH 7.2) for 2 hr at 4°C.
The cells were postfixed with 1% osmic acid for another 2 hr at 4°C, followed by dehydration using ethanol in graded concentrations.
Subsequently, the sections were incubated with uranylacetate and lead citrate (cat. no. 15326; Sigma), and images were acquired using an Olympus EM208S transmission electron microscope (Olympus, Tokyo, Japan).
| LF model induction and MSC transplantation
Male SPF C57BL/6 mice (2 months of age, average body weight: 25 g) were obtained from Chengdu Dossy Experimental Animals Co. Ltd.
(Chengdu, China). Gli1CreER t2 (cat. no. 007913) and Rosa26tdTomato (cat. no. 007909) mice were obtained from Jackson Laboratories (Bar Harbor, ME). For lineage-tracing studies, 6-7-week-old male mice underwent three intraperitoneal injections of tamoxifen (cat. no. 06734; Sigma) at a dose of 0.1 mg/kg body weight in corn oil/3% ethanol 10 days before LF induction. Detailed information on identification of Gli1 genetic lineage-tracing mice is given in the Supporting Information Materials. LF mice were induced by CCl 4 olive oil solution (CCl 4 :olive oil = 1:3) via intraperitoneal injection at a concentration of 4 ml/kg twice per week for 5 consecutive weeks (CCl 4 mice). Accordingly, the control group mice were then subjected to the same concentration of olive oil by intraperitoneal injection (oil mice).
MSCs of passage 5 (P5) infected with lentivirus-control shRNA were transplanted into oil mice and CCl 4 mice at a density of 1 × 10 6 cells in 100 μl normal saline per mouse via the tail vein (on Week 5, n = 8). Mice were euthanized at 0 and 72 hr after cell administration. In subsequent in vivo experiments, 32 mice were randomly designated into four groups with comparable mean body weights; the groups were as follows: oil + PBS, CCl 4 + PBS, CCl 4 + shNC, and CCl 4 + shBecn1 groups (n = 8 each). In the CCl 4 + PBS, CCl 4 + shNC, and CCl 4 + shBecn1 groups, CCl 4 -induced LF model mice were subjected to weekly administration of PBS, shNC-MSCs (1 × 10 7 /ml, P5), or shBecn1-MSCs (1 × 10 7 /ml, P5) from Weeks 3 to 5 via the tail vein. The oil + PBS group underwent PBS administration with the same volume and sequence as the treatment group after oil treatment. The mice were killed 3 days after cell transplantation. In some in vivo experiments, 32 mice were randomly allocated to four groups, that is, oil + shNC, oil + shBecn1, CCl 4 + shNC, and CCl 4 + shBecn1 groups (n = 8 each). shNC-MSCs or shBecn1-MSCs were administered to oil mice or CCl 4 mice (on Week 5) via tail vein. The mice were euthanized 3 days after cell transplantation for subsequent evaluation of the localization of exogenous MSCs in the liver.
All animal operations were conducted in line with the Chinese 
| Immunofluorescence staining
Mice were euthanized, and livers were resected, embedded into OCT (cat. no. 4583; Sakura), and stored at −80°C. Following cutting, frozen sections were permeabilized using 0.5% Triton X-100 (cat. no. ST795; Beyotime, Shanghai, China) and blocked with 5% bovine serum albumin (BSA, 
| Western blot analysis
Total protein from 100 mg mouse liver tissues and MSCs subjected to the above-mentioned treatments was obtained using RIPA lysis buffer with the protein inhibitor phenylmethylsulfonyl fluoride (cat. no. ST506; Beyotime). The total protein was quantified using a BCA quantification kit (cat. no. P0010; Beyotime). Proteins were separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The proteins in gel were shifted to PVDF membranes (cat. Millipore) overnight at 4°C. Membranes were then thoroughly rinsed by TBS-T and subjected to incubation of peroxidase-labeled secondary antibodies (cat. no. SA00001-1; Proteintech) for 1 hr at room temperature. The membranes were rinsed by TBS-T and then incubated with chemiluminescent HRP substrate (cat. no. WBKLSO100; Millipore). Proteins were detected with a chemiluminescence apparatus (Bio-Rad, Hercules, CA).
| Measurement of liver hydroxyproline content
Following the manufacturer's instructions, liver hydroxyproline levels were quantified by hydroxyproline detection kit (Nanjing JanCheng Biochemical Institute, Nanjing, China).
| Measurement of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels
Serum concentrations of AST and ALT were detected to estimate the degree of hepatic injury caused by CCl 4 administration. Mice were anesthetized as described above, and 0.5 ml blood was obtained from the eye sockets of mice, followed by 10 min of centrifugation at 3,000 rpm.
Based on the provided protocol, serum levels of AST and ALT were assessed by diagnostic quantification kits (cat. nos. C010-2 and C009-2; Nanjing JianCheng Bioengineering Institute, Nanjing, China).
| Coculture of MSCs and HSCs
MSCs and HSCs were cocultured in a Transwell coculture system (12-mm diameter; 0.4-mm pore size, cat. no. G3401; Corning, Corning, NY) with DMEM-low glucose containing 10% FBS. Briefly, HSCs at a density of 5 × 10 4 cells/well were cultivated in the bottom chambers of 24-well plates, and MSCs at a density of 2.5 × 10 3 cells/ well were seeded on the Transwell membrane inserts. Three groups were evaluated, that is, control, HSCs + shNC-MSC, and HSCs + shBecn1-MSC groups, with four wells per group. The HSCs were collected for analysis of proliferation and procollagen type I α1 secretion after coculturing for 24, 48, and 72 hr.
| Enzyme-linked immunosorbent assay (ELISA)
After coculture with MSCs for 72 hr, HSCs were collected, and supernatants were obtained to determine secretion of procollagen type I α I (cat. no. ab210579; Abcam) using an ELISA kit. The absorbance (OD value) was measured at 450 nm. shNC-MSCs and shBecn1-MSCs were incubated with TNF-α (20 ng/ml), IFN-γ (50 ng/ ml), and TGF-β1 (10 ng/ml) alone or in combination for 24 hr.
Supernatants were then obtained to detect prostaglandin E 2 (PGE 2 ) secretion using a PGE 2 ELISA kit (cat. no. KGE004B; R&D Systems).
For in vivo experiments, the levels of serum PGE 2 , TNF-α, TGF-β1, and IFN-γ were determined using PGE 2 , TNF-α (cat. no. KE10002; Proteintech), IFN-γ (cat. no. KE10001; Proteintech), and TGF-β1 (cat. no. KE10005; Proteintech) ELISA kits.
| Real-time PCR
Total RNA of MSCs was extracted at the indicated time points with TRIzol Reagent (Invitrogen, Carlsbad, CA). Synthesis of complementary DNA (cDNA) from mRNA was performed via reverse transcription with an iScript cDNA synthesis kit (cat. no. 170-8890; Bio-Rad).
qPCR was conducted in triplicate using SYBR Green Supermix (cat.
no. 172-5271; Bio-Rad). GAPDH was utilized an internal control. The primer sequences are listed in Table 1 .
| Statistical analysis
All data are expressed as means ± SEMs, and were statistically analyzed using GraphPad Prism 5 (GraphPad Software Inc., La Jolla, CA). Means of two groups were compared by Student's t tests. For multiple comparisons, statistical analysis was performed by analysis of variance. A p < .05 was considered statistically significant.
| RESULTS
| Autophagy of MSCs occurred in a LF microenvironment
To determine whether autophagy of MSCs occurred during LF, EGFP-control lentivirus-transfected MSCs (shNC-MSCs) were transfused into oil mice or CCl 4 mice via the tail vein. Interestingly, the number of EGFP + MSCs and the extent of MAP1LC3 puncta in the
Abbreviations: Fw, forward primer; PCR, polymerase chain reaction; Rv, reverse primer.
| LF-related cytokines triggered autophagy in MSCs via upregulation of BECN1
To determine whether the autophagy activated by LF-related cytokines was triggered by upregulating BECN1, MSCs were stimulated with the three cytokines alone or in different combinations for 6 hr. All treatments significantly upregulated mRNA and protein expression of BECN1 (Figure 1f ,g) downregulated p62
protein expression ( Figure 1g ).
To further explore the function that BECN1 played in autophagy, lentivirus-expressing shRNA specific to Becn1 (shBecn1-MSCs) was used to downregulate BECN1 expression in MSCs. Subsequently, the cells were cultivated with or without TNF-α, IFN-γ, and TGF-β1. For the control group, MSCs were transfected with a lentivirusexpressing scrambled shRNA (shNC-MSCs). We revealed that Becn1 livers were significantly reduced after transplantation of shBecn1-MSCs (Figure 3c,d) . These results unveiled that the promoted antifibrotic capability of shBecn1-MSCs in LF might be attributed to their inhibitory effects on HSCs proliferation.
| shBecn1-MSCs attenuated infiltration of CD4 + and CD8 + T lymphocytes in CCl 4 -induced fibrotic livers
The involvement of CD4 + and CD8 + T lymphocyte infiltration in LF has been confirmed (Pesce et al., 2006; Wynn, 2004) . (Ge, Huang, & Yao, 2018) . TGF-β1 is an important profibrotic factor and an immunomodulatory molecule (Fujio et al., 2016) . Due to the different effects of these factors, there may be differences in the timing of induction of autophagy in MSCs. In vitro studies in MSCs further confirmed the crosstalk between autophagy and the LF microenvironment, consistent with our in vivo findings and with the previous findings demonstrating that TNF-α and IFN-γ could activate autophagy in various cell types (Yuan et al., 2018) . Moreover, our results were further supported by a study confirming that TGF-β1
stimulates autophagy, suggesting that autophagy may participate in fibrosis via the TGF-β1 pathway (Ghavami et al., 2015) . Taken together, these findings suggested that the microenvironment of LF, as defined by chronic inflammatory responses involving the proinflammatory factors TNF-α and IFN-γ and the subsequent repair process regulated by the profibrotic factor TGF-β1, triggered autophagy in MSCs both in vivo and in vitro.
We also found that the three LF-related cytokines upregulated both the mRNA and protein expression of BECN1, and downregulated p62 protein expression in MSCs. Consistent with this, Becn1 knockdown reduced the MAP1LC3-II/MAP1LC3-I ratio and increased P62 expression in MSCs. These findings suggested that the autophagy triggered by the three LF-related cytokines might be attributed to BECN1 upregulation in MSCs, which supported the past research demonstrating that IFN-γ and TNF-α trigger BECN1 expression to induce autophagy (Djavaheri-Mergny et al., 2006; Tu et al., 2011) and that autophagy is inhibited by reducing TGF-β1 secretion and TGF-β1/Smad signaling (T. Liu et al., 2018) .
As an evolutionarily highly conserved cellular process, autophagy functions to maintain intracellular homeostasis (Cadwell, 2016) .
Emerging evidence has shown close crosstalk between autophagy and immunomodulation (Clarke & Simon, 2018) . Moreover, autophagy plays pivotal role in T-cell homeostasis and can modulate Th1/
Th2 T-cell responses (Deretic, 2012) . In the present study, we revealed the promoted antifibrotic capability of shBecn1-MSCs in LF in contrast to that in shNC-MSCs. Importantly, proinflammatory cytokines are a prerequisite for MSCs to exert their immuneinhibitory functions (Ren et al., 2008 (Dang et al., 2014) found that inflammatory condition hampered the immunoinhibitive potential of MSCs by priming autophagy in a mouse model of experimental autoimmune encephalitis, supporting our findings. Similar results indicating protective effect of bone MSCs on n-hexane-induced neuropathy through autophagy inhibition were also found in another study (Hao et al., 2018) . Collectively, our results demonstrate that counteracting LF microenvironment-induced autophagy via stable knockdown of Becn1 remarkably promotes the antifibrotic effects of MSCs.
Myofibroblasts derived from HSCs are a potential therapeutic target for antifibrotic therapies (Puche, Saiman, & Friedman, 2013) .
Interestingly, a genetic lineage-tracing analysis performed by Kramann et al. (2015) strongly suggested that Gli1 is a specific biomarker for myofibroblast progenitors. Our results suggested that shBecn1-MSCs inhibited the proliferation of HSCs both in vivo and in vitro and decreased the secretion of procollagen I α1 in HSCs in an in vitro coculture system. These findings affirmed that the inhibitive function on HSCs proliferation might contribute to the augmented therapeutic consequence of shBecn1-MSCs in LF.
The onset and progression of LF are closely related to T-cellmediated immune responses (Pesce et al., 2006; Wynn, 2004) , and the regulatory effect of MSCs on T lymphocyte proliferative capability confers them attractive candidates for antifibrotic treatment (Ren et al., 2008) . Moreover, autophagy is imperative for both survival and immune function of CD4 + and CD8 + T lymphocytes (Jia et al., 2015) . In this regard, the roles of autophagy played in the immunosuppressive properties of MSCs were exploited. Our results showed that transplanted MSCs were selectively recruited to the fibrotic portal area in the liver. Furthermore, shBecn1-MSCs obviously promoted the immunosuppressive capability of MSCs in CD4 + and CD8 + T lymphocyte proliferation. This finding suggested that the inhibitive effect of shBecn1-MSCs on infiltration of CD4 + and CD8 + T lymphocytes might partially account for the elevated antifibrotic effects on the fibrotic liver. Our study corroborated previous research by Ding et al. (2014) , who showed that autophagy alleviates kidney fibrosis by regulating TGF-β1 expression. However, one study showed that MSCs exert immunosuppressive effects in CD4 + T lymphocytes via TGF-β1 secretion and activation of autophagy (Gao et al., 2016) . The cause for this discrepancy may be associated with the molecular interplay between autophagy and immunity; indeed, autophagy functions in both activation and inactivation of immune signaling, thus balancing immune responses (Saitoh & Akira, 2010) . Moreover, these discrepancies may be related to differences in the study designs, including tissue and species origins, cell isolation methods, T cell/MSC ratios, cell culture conditions, and time of data analysis.
The therapeutic effects of MSCs in inflammatory diseases is largely due to their unique capacity to secrete immunoregulatory factors (Ranganath, Levy, Inamdar, & Karp, 2012) . Moreover, the colocalization of exogenous MSCs, T lymphocytes, and HSCs in the portal fibrotic area in CCl 4 -induced fibrotic livers indicated that the inhibition of exogenous shBecn1-MSCs on proliferative capacity of HSCs and T lymphocytes might affect their immunosuppressive capability via a paracrine pathway, but not via hepatocyte regeneration. PGE 2 is an inflammation-induced immunosuppressive agent secreted by MSCs, which mediates MSC-dependent inhibition on T lymphocytes (M. Bai et al., 2018) . Notably, we found that knockdown of Becn1 suppressed inflammation-induced autophagy and generated more PTGS2/PGE 2 in MSCs, consistent with other studies. As outlined by Dang et al. (2014) interactions with components of the immune system (Alfaifi et al., 2018) . MSCs can secrete various immunoinhibitive cytokines, including indoleamine 2,3-dioxygenase, IL-6, nitric oxide, and IL-10 (Shi et al., 2012) . Therefore, we believe that there are other molecules involved in the mechanisms through which shBecn1-MSCs modulate T cells and PGE 2 , and these factors should be investigated in the future. Blocked autophagy may cause cellular senescence (Ma et al., 2018) and increase the risk of tumor formation (Aita et al., 1999; Levy et al., 2014; Qu et al., 2003; Wang et al., 2019) .
Autophagy levels are significantly reduced in aging bone marrow MSCs. In turn, elevated activity of autophagy can partially reverse this senescence and restore bone loss in aged mice. Under certain conditions, loss of the Becn1 gene in mice promotes tumorigenesis (Qu et al., 2003) . In many human tumors, including breast, ovarian, and prostate cancers, the Becn1 gene is often partially deleted (Aita et al., 1999) . These findings indicate that controlling the autophagic activity by genetic manipulation may affect the stem-like characteristics and differentiation functions of MSCs and increase the risk of tumor formation. Therefore, in future studies, it will be necessary to develop a safe and stable method for regulating autophagy. 
